Signal transduction as a drug-discovery platform

Nature Biotechnology

Volumn 16, Issue 11, 1998, Pages 1082-1083

  Persidis, Aris ^a  

^a Upstate Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BEXAROTENE; CYCLIC AMP; CYTOKINE; DNA; DRUG; ENZYME INHIBITOR; FAS ANTIGEN; GLYCOPROTEIN; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HORMONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LEFLUNOMIDE; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTRANSMITTER; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN; PROTEIN BCL 2; PROTEIN KINASE C; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; CELL DIVISION; CLINICAL TRIAL; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SHORT SURVEY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; BIOTECHNOLOGY; DRUG DESIGN; DRUG INDUSTRY; HUMANS; SIGNAL TRANSDUCTION;

EID: 0031737627     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/3553     Document Type: Short Survey

References (10)

1. Koman, A. et al. 1979. J. Bacteriol. 138:739-747.
2. Eckhart, W. et al. 1979. Cell 18:925-933.
3. Hunter, T. and Sefton, B.M. 1980. Proc. Natl. Acad. Sci. USA 77:1311-1315.
4. Ushiro, H. and Cohen, S. 1980. J. Biol. Chem. 255:8363-8365.
5. Smith, M.R. et al. 1986. Nature 320:540-543.
6. Cook, S.J. and McCormick, F. 1993. Science 262:1069-1072.
7. Wu, J. et al. 1993. Science 262:1065-1069.
8. Kerr, J.F.R. et al. 1972. Br. J. Cancer 26:239-257.
9. Persidis, A. 1998. Nat. Biotechnol. 16:100-101.
10. Persidis, A., 1998. Nat. Biotechnol. 16:393-394.